Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongtian oral liquid versus rizatriptan for acute attacks in chronic migraine
ChiCTR1900028542Phase 4Not yet recruiting
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tongtian oral liquid and rizatriptan in chronic migraine (2 arms), sponsored by Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoints: Common carotid artery diameter, Diffusion tensor magnetic resonance imaging and 13 more. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
Tongtian oral liquidrizatriptan
03
Conditions
chronic migraine
Beyond the preview
Go deeper on ChiCTR1900028542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028542.